NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Anna De Benedetto, MD

Advertisement

Articles by Anna De Benedetto, MD

The Science of Atopic Dermatitis With Anna De Benedetto, MD

ByAnna De Benedetto, MD,Kaitlyn Bader, Editor
May 1st 2023

De Benedetto shares her expertise on new discoveries in the science of atopic dermatitis at RAD 2023.

Advertisement

Latest Updated Articles

  • The Science of Atopic Dermatitis With Anna De Benedetto, MD
    The Science of Atopic Dermatitis With Anna De Benedetto, MD

    Published: May 1st 2023 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus

2

The “6-7” Advances for Dermatologists to Look Forward to in 2026

3

Obagi Launches ALOHA Program to Capture Real-World Insights in Aesthetic Injectables

4

Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia

5

New Research Highlights Significant Knowledge Gaps in Patients Using Oral Acne Medication

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us